Questions

Answers

1. What indications are currently covered by Medicare and Medicaid for ¹⁸F-FDG PET scan in melanoma?

A. initial treatment strategy, except for regional lymph node staging

B. initial staging of regional lymph nodes

C. subsequent treatment strategy evaluation

D. all of the above

1. A and C

2. Which of the following statements regarding melanoma is true?

A. PET is sensitive compared with other imaging modalities for evaluation of distant metastases that are widespread and in unusual locations.

B. Head-to-toe imaging is performed.

C. CT is best for detection of sub-centimeter parenchymal lung lesions, and MRI is better for detection of brain metastasis.

D. PET does not replace sentinel lymph node scintigraphy evaluation.

E. all of the above

2. E, all of the above

3. Which of the following statements concerning primary cutaneous melanoma are true? (Choose as many as apply.)

3. A, B, and C

4. Which of the following statements concerning cutaneous melanoma are true? (Choose as many as apply.)

A. Sentinel node localization (SLN) and biopsy are important for initial staging.

B. FDG PET is sensitive for detecting regional lymph node involvement and can substitute for SLN localization.

C. Computed tomography (CT) or magnetic resonance imaging (MRI) is the imaging procedure of choice for detecting small lung metastasis and brain metastasis.

D. The serum lactic dehydrogenase level is sensitive in predicting liver metastasis.

Related posts:

Instrumentation Quality Control Genitourinary Thyroid Gland and Endocrine System Pulmonary Musculoskeletal

Stay updated, free articles. Join our Telegram channel

Join

Full access? Get Clinical Tree